vimarsana.com

Latest Breaking News On - Head of research development - Page 3 : vimarsana.com

Avacta : Preliminary Results for the Year Ended 31 December 2023

Ocugen to Present on Modifier Gene Therapy Platform at

Ocugen to Present on Modifier Gene Therapy Platform at Association for Research in Vision and Ophthalmology 2024 Annual Meeting

MALVERN, Pa., April 26, 2024 Ocugen, Inc. , a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, and vaccines, today announced that the.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.